Filing Flows › Neuroone Medical Technologies (NMTC) › Q2 FY26 › vs Q2 FY25
Neuroone Medical Technologies (NMTC) Q2 FY26 vs Q2 FY25 (year over year)
Neuroone Medical Technologies's revenue rose $476K (+34%) from $1.4M in Q2 FY25 to $1.9M in Q2 FY26.
Neuroone Medical Technologies, Q2 FY26: revenue $1.9M (+34% year over year), operating margin -128.7%, net loss $2.4M, operating cash flow −$1.3M. The chart draws each line against Q2 FY25, the increases inside each band.
Every line
| Line | Q2 FY26 | Q2 FY25 | Change | % |
|---|---|---|---|---|
| Revenue | $1.9M | $1.4M | $476K | +34% |
| Other income, net | $15K | $409K | −$394K | -96% |
| Net loss | $2.4M | $2.3M | $111K | +5% |
| Costs & expenses | $4.3M | $4.1M | $193K | +5% |
| Operating costs | $4.3M | $4.1M | $193K | +5% |
| Cost of revenue | $872K | $615K | $256K | +42% |
| Research & development | $1.5M | $1.5M | −$43K | -3% |
| SG&A | $1.9M | $1.9M | −$21K | -1% |
| Operating cash sources | $2.4M | $2.3M | $111K | +5% |
| Depreciation & amortization | $60K | $66K | −$6K | -9% |
| Share-based compensation | $342K | $250K | $92K | +37% |
| Working capital & other | $651K | $1.9M | −$1.2M | -66% |
| Cash used in operations | $1.3M | $56K | $1.3M | 24× |
| Net loss absorbed | $2.4M | $2.3M | $111K | +5% |
Questions
How much did Neuroone Medical Technologies's revenue grow year over year in Q2 FY26?
Neuroone Medical Technologies's revenue rose $476K (+34%) from $1.4M in Q2 FY25 to $1.9M in Q2 FY26.